Zymeworks Inc. (NASDAQ: ZYME) completed its acquisition of Theravance Biopharma on Sept. 23, 2026, making Theravance Biopharma a part of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE